APELLIS PHARMACEUTICALS INC

Ticker: APLS CUSIP: 03753U106 Class: Common Stock

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 118,724 Value ($000) $2,055 Avg Close $18.51 Range $16.10 - $23.77
Q1 2025
Shares 131,895 Value ($000) $2,885 Avg Close $27.62 Range $21.70 - $35.57
Q4 2024
Shares 13,478 Value ($000) $430 Avg Close $30.07 Range $24.34 - $35.72
Q2 2023
Shares 149,976 Value ($000) $13,663 Avg Close $86.28 Range $73.80 - $94.75
Q1 2023
Shares 151,995 Value ($000) $10,026 Avg Close $57.70 Range $44.92 - $70.75
Q4 2022
Shares 76,881 Value ($000) $3,976 Avg Close $53.04 Range $42.15 - $66.80
Q3 2022
Shares 5,314 Value ($000) $363 Avg Close $59.17 Range $44.07 - $70.00
Q4 2021
Shares 9,406 Value ($000) $445 Avg Close $39.37 Range $30.17 - $50.31
Q3 2021
Shares 77,495 Value ($000) $2,554 Avg Close $56.19 Range $27.50 - $73.00
Q2 2021
Shares 18,421 Value ($000) $1,164 Avg Close $51.60 Range $40.53 - $66.07